Notice Type
Consent to the Distribution of New Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicines set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Cabergoline 0.5 mg Tablet Farmitalia Carlo Erba s.r.l., Rodano (MI), Italy Dostinex Paracetamol 60 mg, 125 mg, 500 mg Suppositories Astra Pharmaceuticals Production AB, Sodertalje, Sweden Prednisolone 1 mg, 5 mg Note: Not to be marketed as substitutable for any other prednisolone product as if the two (2) products were bioequivalent. This replaces the entry in the notice published in the New Zealand Gazette, 10 February 1994, No. 11, notice number 1051, page 721 Tablets Douglas Pharmaceuticals Limited, Technical Division, Mount Roskill, Auckland D-galactose 38% w/v Granules and solution for injection (contrast agent) Schering AG., Berlin, Germany Echovist 200 Echovist 300 Fluvastatin mono-sodium salt 21.06 mg (corresponding to 20 mg fluvastatin free acid), 42.12 mg (corresponding to 40 mg fluvastatin free acid) Capsules Sandoz Pharma Limited, Basle, Switzerland Lescol Dated this 9th day of March 1994. C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 25th day of June 1993.
Publication Date
17 Mar 1994

Notice Number


Page Number